0001437749-23-010869.txt : 20230424
0001437749-23-010869.hdr.sgml : 20230424
20230424090028
ACCESSION NUMBER: 0001437749-23-010869
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230421
FILED AS OF DATE: 20230424
DATE AS OF CHANGE: 20230424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VACZY CATHERINE M
CENTRAL INDEX KEY: 0001177176
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38244
FILM NUMBER: 23838039
MAIL ADDRESS:
STREET 1: C/O PHASE III MEDICAL, INC.
STREET 2: 330 SOUTH SERVICE ROAD, SUITE 120
CITY: MELVILLE
STATE: NY
ZIP: 11747
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Genprex, Inc.
CENTRAL INDEX KEY: 0001595248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900772347
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRINITY STREET, BLDG. B
STREET 2: SUITE 3.322
CITY: AUSTIN
STATE: TX
ZIP: 78712
BUSINESS PHONE: 512-537-7997
MAIL ADDRESS:
STREET 1: 1601 TRINITY STREET, BLDG. B
STREET 2: SUITE 3.322
CITY: AUSTIN
STATE: TX
ZIP: 78712
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-04-21
0001595248
Genprex, Inc.
GNPX
0001177176
VACZY CATHERINE M
3300 BEE CAVE ROAD
#650-227
AUSTIN
TX
78746
1
EVP GC Chief Strategy Officer
0
Common Stock
2023-04-21
4
P
0
20000
1.0739
A
265000
D
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.08 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Catherine Vaczy
2023-04-24